Research Agenda Setting Discussion Series
During the co-creation series last year, participants identified a need to continue discussions on how to effectively engage policy makers and other end-users, navigate in fragile states or during times of crisis, and continue to build capacity to ensure alignment of research agenda with government broadly for agenda-setting activities.
In response, Action Group 5 is organizing a series of discussions, starting with a panel inviting senior policymakers and HPSRIs to share insights on how to establish research priorities that would promote the use of evidence in policy making in countries that have lower capacity for evidence-based policy making.
The discussion series is now complete and was held from February-May 2022 and featured policymakers, CSOs and funders.
Panel 3 Synthesis
To view the recording, click here.
AG 5_Models of Research Agenda Setting_Meeting 3.pdfPanel 3 Background
The third and final discussion in this series will explore the role development partners and funding play in influencing how research agenda setting is prioritized. This discussion will focus on the following questions:
In developing countries, especially in fragile states, how do multiple funding streams from development partners influence research priorities?
How does foreign funding impact on priority setting in developing countries?
Panelist 3 Bios
Eduardo Banzon
Principal Health Specialist, Southeast Asia Department, Asian Development Bank
Sarbani Chakraborty
Senior Program Director, Results for Development
Dr. Sarbani Chakraborty is a recognized global health leader with over 20 years of experience shaping resilient and sustainable health systems in Africa, Europe and Central Asia, the Middle East, and Asia working with the public and private sectors.
Dr. Chakraborty is a senior program director at Results for Development (R4D), where she oversees the mixed health systems (MHS) practice area. In this role, she manages partner and donor relationships, thought leadership, and program design and implementation for mixed health systems, including for the Frontier Health Markets Global Technical Assistance program, a 5-year USAID-funded initiative that aims to increase private sector engagement to improve voluntary family planning, maternal and child health, malaria and HIV/AIDS, for which R4D is the technical co-lead.
Benoit Mathivet
Manager of Strategic Partnerships and Blended Finance, Global Fund
Benoit Mathivet is currently the Manager for Strategic Partnerships and Blended Finance as part of the Health Finance Department of the Global Fund where he promotes the use of innovative health financing instruments to leverage more resources for health system strengthening and the fight against the AIDS, TB and Malaria.
He was previously a Senior Health Economist at the World Bank and a Health System Advisor at WHO, during which he constantly supported the development of national analytical capacity to sustain health policy dialogue with home-grown evidence. He was notably the adviser to the Health Policy Analysis Unit of the Ministry of Health of the Republic of Tajikistan from 2009 to 2012.
Discussion Series: Part 2
Panel Synthesis
To view the recording, click here.
AG 5_Models of Research Agenda Setting_Meeting 2.pdfPanel Background
The second discussion will explore the role of civil society organizations in influencing the research agenda setting process in fragile or conflict affected states and supporting the development of a resilient health system. This discussion will revolve around the following questions:
In situations where the government does not have a big footprint in service delivery/health system strengthening, how do you identify research needs and ensure that these align with government priorities?
CSOs are traditionally program/population/location specific. How do you amplify the findings/learnings from implementing a narrow mandate to reach a wider audience, particularly policymakers?
How do you share findings from your implementation research to generate impact on the wider health system?
Panelist Bios
Dr. Sushil Chandra Baral
Managing Director of HERD International, Nepal
He has contributed to the design of DFID’s support programme to Nepal Health Sector Programme 1 and 2, including design of technical assistance to the Ministry of Health and responsibly managed DFID support to the Ministry of Health under the health sector programme-1 and 2. He is skilled in programme based operational research and scale-up of evidence based best practices with a long-term involvement in Nepal’s health sector in particular disease control programmes in developing countries.
He has also gained knowledge and experience in operational research, development of sector wide approach, health service decentralisation, health sector reform, strategic planning, health policy and management.
Dr. Prashanth N Srinivas
Assistant Director for Education of the Institute of Public Health, India
Prashanth N Srinivas is a medical doctor and public health researcher with experience working in primary health care and community settings in southern Karnataka. He has worked at the intersections of healthcare and health systems with ecological and social systems with a particular focus on health inequities and social determinants of health. He leads the health equity cluster at the Institute of Public Health, Bengaluru, where his work critically examines the transformative dimensions of technological solutions to health inequities vis-a-vis addressing fundamental issues of social inequality, exclusion and governance.
He served as the Chair of Emerging Voices for Global Health (2015-2019) and is a member of the General Council of the Institute of Tropical Medicine, Antwerp (Belgium) and has several publications in international peer-reviewed journals. Through a fellowship from the DBT/Wellcome Trust India Alliance, he has set up collaborations to examine health inequities in indigenous communities in multiple remote forested locations in southern, central, and northeast India. He has experience using health policy and systems research methods particularly realist evaluation, implementation research, and participatory action research approaches in addition to experience with quantitative epidemiological methods. He is part of a research consortia on health systems strengthening for OneHealth and mental health in primary health care.
Discussion Series: Part 1
Panel Synthesis
To view the recording, click here.
AG 5_Models of Research Agenda Setting_Meeting 1.pdfPanel Background
Objectives of the first discussion include:
To share insights on how to establish research priorities that would promote the use of evidence in policy making in countries that have lower capacity for evidence-based policy making. This includes contexts where:
a) health is a sub-national issue (e.g., India, Indonesia, China, Nepal, Philippines) and for which policy decisions differ across the country
b) there is limited functioning government and/or fragile states
Panelist Bios
Manuel M. Dayrit MD, MSc
Adjunct Professor and Former Dean, Atenea School of Medicine and Public Health
As one of the leading epidemiologists in the Philippines, he is active in COVID-19 control efforts through private sector engagement with national government and local government units. He continues to teach and do research as Adjunct Professor at the Ateneo de Manila University School of Medicine and Public Health.
Over his professional life and various engagements, Dr. Dayrit has seen the evolution of the country’s health system. He has been involved in many of the Department of Health’s phases of reform and organizational development from the 1970s to the present.
Dr. T. Sundararaman MBSS, MD
Former Executive Director, National Health Systems Resource Center
Professor T. Sundararaman is now retired and staying in Pondicherry. His career has included an important contribution to academics, a major contribution to making and implementing health policy, and an active role in civil society organizations, building and guiding many peoples science and health movements.
His engagement with policy and implementation of health systems strengthening began with his deputation to the position as first Director of State Health Resource Cente Chhattisgarh and then as Executive Director of National Health Systems Resource Center. In the latter role, he contributed significantly to the design and implementation of the NRHM. He has served as member or chairperson on a number of important policy committees as well as joint monitoring missions at international, national, and state level. He is currently chair of the Technical Advisory Committees for Health Technology Assessment of the Department of Health Research, Government of India.
Facilitator and Action Group Co-lead Bios
Dr. Leizel Lagrada-Rombaua
Senior Fellow, Results for Development
Dr. Nima Asgari-Jirhandeh
Director, Asia Pacific Observatory on Health Systems and Policies, WHO
Dr. Nima Asgari was trained in public health medicine in London and has been working in the field since 1996. He has been with WHO since 2006 where he worked at their HQ in Geneva as well as China, Cambodia, and Thailand country offices. Nima became the director of the Asia Pacific Observatory on Health Systems and Policies (APO) in October 2016.
His focus is on expanding membership of APO, increasing the range and number of APO publications, and most importantly, increasing the capacity of health system research in the region and shifting the evidence to policy. Before joining WHO, Nima worked in UK for the Health Protection Agency, the National Institute for Health and Care Excellence (NICE) and local health authorities in London and environs, providing public health services to local population.
Dr. Kyu Kyu Than
Senior Technical Coordinator, Myanmar Program, Burnet Institute
A three-time winner of the Best Paper award for Health Systems Research by the Ministry of Health in Myanmar, she has also been involved in more than 20 research projects as a principal investigator and has published more than 15 research articles.
Her main interest is to help poor and vulnerable populations through evidence-based policy research.